Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-014717
Filing Date
2016-07-05
Accepted
2016-07-05 17:21:03
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4063016taglich_icagen.html 4  
1 OWNERSHIP DOCUMENT f4063016taglich_icagen.xml 4 5963
  Complete submission text file 0001213900-16-014717.txt   7646
Mailing Address TAGLICH BROTHERS INC 1370 AVENUE OF THE AMERICAS --31ST FLOOR NEW YORK NY 6317254791
Business Address
TAGLICH MICHAEL N (Reporting) CIK: 0001024533 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54748 | Film No.: 161751580

Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Issuer) CIK: 0001518520 (see all company filings)

EIN.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research